Ozurdex TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: dexamethasone
Pack: Ozurdex 700 microgram implant, 1, applicator
Brand name
(ARTG)
: OZURDEX dexamethasone 700 microgram Intravitreal implantDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
OZURDEX is indicated for the treatment of:,- Diabetic macular oedema (DME),- Macular oedema due to Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO).,- Non-infectious uveitis affecting the posterior segment of the eye.OZURDEX is indicated for the treatment of diabetic macular oedema (DME).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Implant
- Intravitreal-Within The Vitreous Cavity Of The Eye
- Rod-shaped, solid implant in a single use applicator
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Heat
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 intravitreal implant pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient dexamethasone
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
